๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical benefit of enzyme replacement therapy in Fabry disease

โœ Scribed by Breunig, F; Weidemann, F; Strotmann, J; Knoll, A; Wanner, C

Book ID
110052598
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
113 KB
Volume
69
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Fabry disease: enzyme replacement therap
Fabry disease: enzyme replacement therapy
โœ MR Bongiorno; G Pistone; M Aricรฒ ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB

## ABSTRACT Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an Xโ€linked lysosomal storage disorder caused by a deficiency of ฮฑโ€galactosidaseย A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with ฮฑโ€galacto

Enzyme replacement therapy in Fabry dise
Enzyme replacement therapy in Fabry disease
โœ R. O. Brady; G. J. Murray; D. F. Moore; R. Schiffmann ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Springer ๐ŸŒ English โš– 61 KB
Enzyme replacement therapy and intraepid
Enzyme replacement therapy and intraepidermal innervation density in Fabry disease
โœ Raphael Schiffmann; Peter Hauer; Barbara Freeman; Markus Ries; Leland J. C. Scot ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB

## Abstract We prospectively evaluated the effect of enzyme replacement therapy (ERT) on the intraepidermal nerve fiber density (IENFD) and thermal threshold in patients with Fabry disease, an Xโ€linked disorder associated with a painful smallโ€fiber neuropathy and decreased linear IENFD in a lengthโ€